Home/Filings/4/A/0000914190-18-000575
4/A//SEC Filing

Pinto Moshe 4/A

Accession 0000914190-18-000575

CIK 0001196298other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:12 PM ET

Size

9.1 KB

Accession

0000914190-18-000575

Insider Transaction Report

Form 4/AAmended
Period: 2018-12-14
Pinto Moshe
Director
Transactions
  • Award

    Common Stock

    2018-12-14+47,673204,118 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $0.40Exp: 2026-08-24Common Stock (33,880 underlying)
    33,880
  • Stock Option (Right to Buy)

    Exercise: $0.45Exp: 2025-08-14Common Stock (59,155 underlying)
    59,155
  • Stock Option (Right to Buy)

    Exercise: $0.50Exp: 2027-12-20Common Stock (40,284 underlying)
    40,284
Footnotes (3)
  • [F1]On December 14, 2018, the Company granted 47,673 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Pinto in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
  • [F2]Fully exercisable.
  • [F3]The option vests as to 13,428 shares on each of 12/20/17, 12/20/18 and 12/20/19.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001651255

Filing Metadata

Form type
4/A
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:12 PM ET
Size
9.1 KB